Skip to main content

Cold Spring Harbor Laboratory Joins Illumina Genome Network

NEW YORK (GenomeWeb News) – Cold Spring Harbor Laboratory has joined the Illumina Genome Network, Illumina announced today.

Richard McCombie, a professor at CSHL, said in a statement that his organization seeks to improve the diagnosis and treatment of cancer, neurological disorders, and other diseases, and "by participating in IGN, we are enriching the capabilities of researchers as they strive to solve biology's most challenging problems."

Christian Henry, Illumina's senior vice president and GM of the genomic solutions business, added, "Through the Illumina Genome Network, we believe we can speed discovery in areas where CSHL excels, including approaches to understanding tumor development, progression, and therapeutic response."

Other members in the IGN that provide a full range of whole-genome sequencing services include the Broad Institute; the British Columbia Cancer Agency; the University of Washington Department of Genome Sciences; the National Center for Genome Resources; Macrogen and Genomic Medicine Institute in Seoul, South Korea; and Illumina's FastTrack Services lab in San Diego.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.